Lithium-associated nephropathy.
Colt EW, Igel G, Fieve RR, Dunner DL.
Am J Psychiatry. 1979 Aug;136(8):1098-9. doi: 10.1176/ajp.136.8.aj13681098.
Lithium-associated nephropathy in the renal allograft.
Rodelo-Haad C, Agüera ML, Ortega R, Martinez-Lopez A, Navarro MD, Rodriguez-Benot A, Aljama P.
Kidney Int. 2018 Jan;93(1):273. doi: 10.1016/j.kint.2017.08.032.
Lithium-associated kidney microcysts.
Tuazon J, Casalino D, Syed E, Batlle D.
ScientificWorldJournal. 2008 Aug 31;8:828-9. doi: 10.1100/tsw.2008.112.
Tardive dyskinesia and lithium-associated nephropathy: are you liable?
Gelenberg AJ.
J Clin Psychiatry. 1980 Nov;41(11):368-9.
Molecular mechanisms in lithium-associated renal disease: a systematic review.
Rej S, Pira S, Marshe V, Do A, Elie D, Looper KJ, Herrmann N, Müller DJ.
Int Urol Nephrol. 2016 Nov;48(11):1843-1853. doi: 10.1007/s11255-016-1352-6. Epub 2016 Jun 29.
Lithium-induced nephropathy; One medication with multiple side effects: a case report.
Zhang P, Gandhi H, Kassis N.
BMC Nephrol. 2022 Sep 9;23(1):309. doi: 10.1186/s12882-022-02934-0.
End-stage renal disease associated with prophylactic lithium treatment.
Aiff H, Attman PO, Aurell M, Bendz H, Schön S, Svedlund J.
Eur Neuropsychopharmacol. 2014 Apr;24(4):540-4. doi: 10.1016/j.euroneuro.2014.01.002. Epub 2014 Jan 17.
Lithium and kidney, 60 years later.
Raja M.
Curr Drug Saf. 2011 Nov 1;6(5):291-303. doi: 10.2174/157488611798918737.
Prevention of lithium-associated renal failure: recent evidence.
Davis JM, Rosenbaum A, Shahinian V, Brosius FC.
Lancet Psychiatry. 2015 Dec;2(12):1045-7. doi: 10.1016/S2215-0366(15)00498-8.
Renal pathology associated with lithium therapy.
Walker RG, Dowling JP, Alcorn D, Ryan GB, Kincaid-Smith P.
Pathology. 1983 Oct;15(4):403-11. doi: 10.3109/00313028309085167.
